Fairman Group’s Pfizer PFE Stock Holding History

Fairman Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$94.1K	Buy	3,300 +12	+0.4%	+$319	0.07%	76
2026 Q2	$79.2K	Sell	3,288 -4,828	-59%	-$126K	0.06%	84
2026 Q1	$228K	Buy	8,116 +4,855	+149%	+$129K	0.19%	55
2025 Q4	$81.2K	Buy	3,261 +13	+0.4%	+$328	0.06%	82
2025 Q3	$82.8K	Buy	3,248 +14	+0.4%	+$346	0.07%	81
2025 Q2	$78.4K	Buy	3,234 +13	+0.4%	+$303	0.06%	83
2025 Q1	$85.1K	Buy	3,221 +12	+0.4%	+$314	0.08%	79
2024 Q4	$85.1K	Buy	3,209 +12	+0.4%	+$325	0.07%	85
2024 Q3	$92.5K	Buy	3,197 +11	+0.3%	+$321	0.08%	83
2024 Q2	$89.1K	Buy	3,186 +11	+0.3%	+$303	0.09%	86
2024 Q1	$88.1K	Buy	3,175 +272	+9%	+$7.55K	0.08%	77
2023 Q4	$83.6K	Buy	+2,903	New	+$87.8K	0.08%	82

Other funds holding PFE

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Fairman Group's PFE Position: Q3 2026 in Review

Fairman Group increased its Pfizer (PFE) stake by 0.36% in Q3 2026, buying an estimated $319 and bringing the position to 3,300 shares worth $94.1K. The position accounts for 0.07% of the portfolio, ranked #76.

Fairman Group first reported a position in PFE in Q4 2023 and has held it in 12 quarters since. The position peaked at $228K in Q1 2026. 1,557 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

Fairman Group held 3,300 shares of Pfizer worth $94.1K as of Q3 2026.
Fairman Group bought 12 Pfizer shares in Q3 2026, an estimated $319.
Pfizer made up 0.07% of Fairman Group's portfolio in Q3 2026, its #76 holding.
Fairman Group first reported a position in Pfizer in Q4 2023 and has held it in 12 quarters since.
Fairman Group's Pfizer position peaked at $228K in Q1 2026.
1,557 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Fairman Group's 13F filing for Q3 2026, filed 26 Oct 2026.